FIELD: medicine.
SUBSTANCE: blood is examined for a level of endotoxin and assessed for a degree of particle activation by Endotox spp. MAP and lysate amebocyte assay. The level of endotoxin being 2.5 ng/ml and the degree of particle activation being 2, the absence of a risk of recurrent haemorrhage is predicted.
EFFECT: higher clinical effectiveness in the patients with hepatic cirrhosis, enabled selection of a therapeutic approach.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINATION OF TREATMENT TACTICS FOR PATIENTS WITH RISK OF BLEEDING FROM VARICOSE VEINS OF ESOPHAGUS AND APPLICATION OF ENDOSCOPIC LIGATION TO PREVENT AND STOPPING BLEEDING FROM VARICOSE VEINS OF ESOPHAGUS IN CASE OF PORTAL HYPERTENSION | 2016 |
|
RU2642965C2 |
| METHOD FOR PREDICTION OF FAILURE IN PATIENTS WITH VIRAL AND ALCOHOLIC HEATOCIRRHOSIS | 2008 |
|
RU2381748C1 |
| METHOD FOR PREDICTING RISK OF BLEEDING FROM VARICOSE VEINS OF STOMACH AND ESOPHAGUS AFTER SURGICAL INTERVENTION IN THE SCOPE OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT SHUNTING WITH SELECTIVE EMBOLIZATION OF GASTRIC VEINS | 2022 |
|
RU2804674C1 |
| METHOD FOR DIAGNOSTICS OF VARICOSE VEINS OF ESOPHAGUS IN PATIENTS WITH EXTRAHEPATIC PORTAL VEIN OBSTRUCTION | 2016 |
|
RU2632778C1 |
| METHOD OF MAKING ESOPHAGOGASTROANASTOMOSIS IN PATIENTS WITH PORTAL HYPERTENSION | 2015 |
|
RU2607178C1 |
| METHOD FOR DETERMINING THE RISK OF HYPERCOAGULABILITY IN PATIENTS WITH PORTAL HYPERTENSION OF CYRRHOTIC GENESIS AFTER PORTOSYSTEMIC SHUNT PLACEMENT | 2017 |
|
RU2665118C1 |
| METHOD OF USING CORONARY TECHNIQUES FOR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) | 2016 |
|
RU2660997C2 |
| METHOD OF ESTIMATING RISK OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT SURGERY IN PATIENTS WITH PORTAL HYPERTENSION OF CIRRHOTIC GENESIS | 2011 |
|
RU2492479C2 |
| METHOD OF ENDOSCOPIC HARDENING OF ESOPHAGEAL VARICOSITY | 2008 |
|
RU2357700C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF VIRAL LIVER CIRRHOSIS | 2021 |
|
RU2784344C1 |
